KYTHERA Acquires Worldwide Rights to Clinical Compound and Key Intellectual Property for Potential Novel Treatment of Hair Loss
Go back to KYTHERA Acquires Worldwide Rights to Clinical Compound and Key Intellectual Property for Potential Novel Treatment of Hair Loss| KYTHERA BIOPHRM (NASDAQ: KYTH) | Delayed: 74.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.98 | 52 Week High | $76.31 | |||
| Open | $0.03 | 52 Week Low | $29.86 | |||
| Day High | $74.98 | P/E | N/A | |||
| Day Low | $74.98 | EPS | $-3.35 | |||
| Volume | 6,650 | |||||

